For example, Jiangying Cui et al. showed that ZEB2 activates Wnt/β-catenin pathway to facilitate NSCLC progression [23], Yan Wang et al. proved that ZEB2 promotes epithelial-mesenchymal transition (EMT) [22] and Xiangdong Tong et al. evidenced that ZEB2 promotes cell proliferation and growth [21] in NSCLC. Here, ZEB2 is linked to non-small cell lung carcinoma.